First Analysis acted as the exclusive financial advisor to COPILOT in QHP Capital’s investment in the company

CHICAGO – Jan. 10, 2023 – First Analysis acted as the exclusive financial advisor to COPILOT Provider Support Services, LLC, in QHP Capital’s investment in the company. The terms of the transaction were not disclosed.

COPILOT is a leading provider of technologically advanced healthcare access solutions. Since its inception in 2010, COPILOT has partnered with pharmaceutical companies to help patients and providers navigate access to life-changing therapies and manage reimbursement challenges. The company's highly configurable proprietary technology platform bridges the gap between providers and patients by accelerating patient access to therapy, delivering real-time visibility, and driving improved treatment outcomes.

Dr. Moby Kazmi, President and Co-Founder of COPILOT, said, “Our mission at COPILOT is to help patients in need of specialty therapies overcome access hurdles and accelerate time to treatment. First Analysis understood the importance of finding a partner aligned with our mission. Their deep industry expertise and guidance were invaluable during the process and led us to a great partner in QHP.” Nuaman Tyyeb, CEO and Co-Founder of COPILOT, added, “First Analysis was instrumental in communicating our vision and empowering us to select the ideal partner for COPILOT’s next phase of growth.”

First Analysis focuses its advisory services on high-growth, entrepreneur-driven companies like COPILOT. The First Analysis team worked closely with the co-founders and management team to optimally position the company and find the best partner to help COPILOT to continue to achieve its objectives. First Analysis was actively engaged throughout the transaction process, including preparation, positioning, investor coordination and contact, due diligence and negotiation.


COPILOT is a digital-first patient-centric reimbursement hub services platform intended to support the relationship between patients, health care providers and pharmaceutical and device manufacturers. For more information, please visit

About QHP Capital

QHP Capital is an investor in technology and services companies in the life sciences and healthcare sectors. QHP Capital spun out of NovaQuest Capital Management, which was formed in 2000 with the vision of building an investment platform to provide strategic capital and industry expertise in partnership with strong management teams.

About First Analysis

Founded in 1981, First Analysis has a 41-year track record of serving emerging growth companies and established industry leaders within its focused areas of domain expertise. Our investment banking practice leverages industry insights developed through our research and investing activities to deliver value to clients across the life cycle of a business. Providing senior-level attention to every client, First Analysis offers superior execution across a comprehensive range of investment banking services, including merger & acquisition advisory and growth financings.

Matthew Nicklin
Managing Director

Andrew Walsh
Managing Director

Joseph Munda
Senior Vice President

To download a pdf version of this press release, please follow the link below:
First Analysis acted as the exclusive financial advisor to COPILOT in QHP Capital’s investment in the company

Investment banking and corporate finance services are offered through First Analysis Securities Corporation ("FASC" or "First Analysis Securities"), a subsidiary of First Analysis Corp.
©2023 by First Analysis Corporation.
One South Wacker Drive
Suite 3900
Chicago, IL 60606
First Analysis Securities Corp. (FASC) is a registered broker/dealer with FINRA and member SIPC.